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Introduction {#sec1}
============

Acute injury of organs triggers inflammation and wound healing to restore tissue integrity and function. This rapid repair response involves a complex cascade of inflammatory processes that contain the damage and trigger regeneration ([@bib18], [@bib40]). During this response, instead of the signaling pathways that maintain tissue homeostasis, pathways that control self-propelling yet self-limiting program are active. During the tissue healing response, many diverse cell types, both resident and infiltrating cells, communicate through secreted signals and cell contact to modulate each other\'s behaviors. Some of these behaviors include proliferation and transitions between different cellular states, such as differentiated cells adopting a transient progenitor-like state or quiescent stem cells adopting an activated state ([@bib40]). A critical phase in the repair process is the resolution ([@bib34]), which terminates inflammation and regeneration once the damaged tissue is repaired: excess cells die, return to quiescence, or re-differentiate.

Perfect repair of injury is not always possible, especially when large areas of damage or repeated injuries occur. Consequently, the resolution process is altered resulting in the formation of scars or tissue fibrosis. In some cases, such as chronic kidney disease (CKD) ([@bib15]), chronic progressive fibrosis occurs ([@bib11]) due to excess proliferation of fibroblasts and deposition of the extracellular matrix. Chronic progressive fibrosis impairs organ function and can ultimately lead to organ failure and death. Chronic progressive fibrosis is not simply "incomplete" or "altered" repair; instead, it results from excessive repair activity and failure of resolution and is, thus, a maladaptive response. Fibrosis impairs organ function in heart, kidney, and liver diseases and is a complication that impairs function after organ transplantation and organ health following surgery. For example, ischemic kidney injury is a common consequence of cardiac surgery ([@bib30]).

Here, we used a mouse model of ischemic kidney injury to explore acute injury repair and chronic fibrosis. Exposure to toxins or hypoxic stress can lead to loss of epithelial cells in the renal tubules, causing either acute kidney injury (AKI) with kidney failure or CKD that progresses irreversibly to end-stage renal insufficiency. AKI and CKD are global health challenges with limited treatment options ([@bib41]). These two conditions are often mechanistically and clinically linked ([@bib4], [@bib10], [@bib22]). Although some patients completely recover from AKI, others progress to CKD ([@bib2], [@bib8]). The determining factors for the transition from AKI to CKD are not clear. The risk of CKD increases if a patient survives a single episode of AKI and further increases with repetitive AKI episodes ([@bib7], [@bib9]). In mice, exposing the kidney to mild ischemia prior to injury (ischemic preconditioning) protects against renal damage from a subsequent AKI ([@bib5], [@bib17], [@bib32]). Clinical trials of ischemic preconditioning for AKI associated with cardiac surgery are ongoing ([@bib23], [@bib46]).

Mechanistically, kidney tissue injury stimulates two connected cellular networks (tubular cells and fibroblasts) through signals mediated by the Sonic hedgehog (Shh) and Wnt pathways. Shh released by the kidney tubular cells stimulates the proliferation of activated fibroblasts to promote tissue repair ([@bib49]). Wnt produced by both tubular cells and fibroblasts participates in both repair of injured tissue and stimulation of fibrosis ([@bib1], [@bib38], [@bib42], [@bib50]). In particular, Wnt signaling stimulates cell state transitions, including epithelial-to-mesenchymal transition (EMT) and partial EMT (pEMT), which contribute to both tissue repair and many chronic fibrotic diseases ([@bib15], [@bib35], [@bib39]). After AKI, some kidney tubular epithelial cells undergo pEMT and some activated fibroblasts become myofibroblasts, the latter of which is a critical event in the development of fibrosis ([@bib13], [@bib24]). The Wnt-stimulated process of myofibroblast expansion could serve as a drug target for limiting fibrosis and development of CKD. Consistent with this hypothesis, excessive and prolonged activation of Wnt signaling promotes myofibroblast proliferation and fibrogenesis and correlates with progression to CKD ([@bib42], [@bib50]).

The apparent seemingly contradiction of the beneficial effects of ischemic preconditioning and the established detrimental role of Wnt activation on fibrosis development has led to a long-standing puzzle in the field of AKI and CKD studies. To resolve this controversy, here we combined quantitative experimental studies with a mouse kidney injury model and a nonlinear dynamical systems model of the cellular interaction network composed of a tubular epithelial cell module and a fibroblast cell module, involving three cell states in each module, and regulatory signals mediated by Shh and Wnt. We used this cellular network model to investigate the transition from acute injury and repair to chronic tissue damage and fibrosis. The model provided a mechanism for the multiple outcomes of kidney injury found experimentally in a mouse model. Furthermore, the model predicted a potential increased risk of fibrosis of ischemic preconditioning despite its well-known protective effect, which was validated in a mouse kidney ischemia system. Importantly, we developed a Wnt pathway-targeted treatment regimen involving sequential agonist then antagonist treatment to accelerate tissue repair and prevent fibrosis with the guidance of computational multi-objective optimization. These findings are particularly relevant in the context of surgery when the timing of the ischemic episode is known and treatments can be initiated and strategically planned to optimize positive outcomes.

Results {#sec2}
=======

Mouse Models Reveal Four Discrete Terminal States Depending on the Duration of Acute Kidney Injuries {#sec2.1}
----------------------------------------------------------------------------------------------------

We established a mouse model for AKI (the ischemia-reperfusion injury \[IRI\] model) to study whether varying a single input variable (the severity of transient ischemia) produces qualitatively distinct repair outcomes. If so, then the system is a complex non-linear dynamical system, which has the property that multiple distinct stable outcomes arise in response to a continuous range of a perturbation. We tuned the severity of kidney injury by varying the duration of ischemia ([@bib42]): mild (5 min), moderate (10, 15, and 20 min), and severe (30 min) IRI. All mice exposed to mild IRI survived, four of seven mice exposed to each of the moderate IRI conditions survived, and only six of sixteen mice exposed to severe IRI survived. Surviving mice recovered for 30 days; then we analyzed the kidney tissue by periodic acid-Schiff (PAS) ([Figure S1](#mmc1){ref-type="supplementary-material"}) to evaluate the severity of injury based on morphological changes and marker expressions. We stained for Wnt1, Vimentin, fibroblast specific protein 1 (FSP-1), α-smooth muscle actin (α-SMA), and platelet-derived growth factor receptor-β (PDGFR-β) by immunohistochemistry to monitor the activation of fibroblasts and pEMT ([Figures 1](#fig1){ref-type="fig"}A and 1B). For animals subjected to mild IRI, we observed that all markers returned to basal levels like those in control mice not exposed to IRI. The response to 10-min IRI was more variable: some mice had a small but statistically significant increase in Wnt1, FSP-1, and vimentin, but not PDGFR-β; only one mouse had a statistically significant increase in α-SMA. The other three experimental groups displayed a significant increase in all five markers. Mice exposed to the severe IRI displayed the highest amounts of all of these markers and had large fibrotic patches ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}). In contrast, small and scattered fibrotic patches were observed in mice after 15- or 20-min IRI ([Figure S1](#mmc1){ref-type="supplementary-material"}).Figure 1Mouse Models Show the Existence of Four Possible Outcomes Depending on the Duration of Acute Kidney Injuries(A) Representative micrographs showing expression of Wnt1, FSP-1, Vimentin, α-SMA, and PDGFR-β in control and diseased kidneys 30 days after varying degrees of IRI. Scale bar, 100 μm.(B) Quantification of marker levels. Each column indicates an individual mouse. Data are represented as mean ± SEM of three slices for each marker each mouse. ∗∗p \< 0.005, ∗p \< 0.05 versus control using t test (n = 5).(C) Hierarchical clustering analysis of the marker levels on day 30 after different duration of IRI treatment.(D and E) Temporal profiles of renal function markers, serum creatinine (D) and BUN (E) after various duration of IRI. n = 3, Data are represented as mean ± SEM.(F) The fraction of the dead mice, repair outcomes, myofibroblast expansion, and renal function depends on the duration of IRI.See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Cluster analysis with these markers 30 days after injury divided the surviving mice into three readily distinguishable groups ([Figure 1](#fig1){ref-type="fig"}C) representing the treatment groups, indicating that these markers adequately captured the differences between the mild, moderate, and severe injury conditions. In the mice in the 5-min IRI group, the markers returned to basal, the tissue was morphologically indistinguishable from the control mice, and the mice clustered with the control mice, indicating that the repair response was complete and resolved. Hence, we defined the kidney tissue state in the mice of this cluster as a "perfect adaptive response state" (PARS). The markers of mice in the 15- and 20-min IRI groups indicated the persistence of low levels of Wnt and low numbers of residual activated fibroblasts and pEMT cells; thus, we defined this as an "imperfect adaptive response state" (iPARS). The third cluster of the 30-min IRI group had kidneys with high amounts of Wnt and markers of myofibroblasts and pEMT cells; thus, we defined this as a "maladaptive response state" (MARS).

To determine how increasing the severity of IRI affected kidney function, we evaluated kidney function based on serum creatinine and blood urea nitrogen (BUN), which are routinely used to assess kidney function in patients. By 30 days after IRI, only the mice in the severe IRI group exhibited compromised kidney function ([Figures 1](#fig1){ref-type="fig"}D and 1E). Consistent with the severe IRI and 20-min moderate IRI group exhibiting the most impairment in kidney function (highest serum creatinine and BUN), several animals died in those two groups of mice in the first 2 weeks after the IRI ([Figure 1](#fig1){ref-type="fig"}F).

These data suggest that the kidney response to IRI is a complex non-linear dynamical system. A single quantitative variable, the duration of ischemia, produced four qualitatively distinct outcomes: (1) full adaptive recovery (PARS), (2) imperfect recovery with mild lasting tissue changes but restored kidney function (iPARS), (3) a maladaptive response (MARS) with signs of fibrosis and renal dysfunction, and (4) death.

A Mathematical Model of the Regulatory Network of the Kidney Response to Injury Accurately Recapitulates the Four Observed Outcomes {#sec2.2}
-----------------------------------------------------------------------------------------------------------------------------------

We first asked whether the four distinct and robustly separable outcomes in the animals, triggered by varying the magnitude of one experimentally controllable parameter, reflect inherent dynamical behaviors of the cell-cell interaction network that orchestrates the repair response. We constructed a canonical model with the key components involved in kidney repair ([Figure 2](#fig2){ref-type="fig"}A, [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}). We represented the model with ordinary differential equations with eight variables representing the rates of change in the abundance of cells and the two signaling mediators (Shh, Wnt) ([Supplemental Information](#appsec2){ref-type="fn"}). The cellular components of the network are represented by two modules: the tubular module (representing the tubular epithelial cells) and the fibroblast module, each containing three distinct cell states. Shh and Wnt produced by the cells in the cellular modules mediate the interactions between the two modules. The cells proliferate, undergo state transitions, or die under the influence of these two signaling molecules in response to ischemic injury ("insult" in the model). The outcome variables include (1) the fraction of dead tubular epithelial cells ([Figure S2](#mmc1){ref-type="supplementary-material"}A, see [Supplemental Information](#appsec2){ref-type="fn"}: The fate of organism death in the mathematical model) and (2) the abundance of myofibroblasts. We selected the number of myofibroblasts as a determinant of the outcome related to fibrosis, because the abundance of myofibroblasts is a major determinant of this pathology through secreting extracellular matrix (ECM) ([@bib21]). Thus, the effect of ECM is implicated included in the model based on a positive correlation between the number of fibroblasts and ECM. Using these variables, we set to examine whether the system could reproduce multiple clinically and experimentally observed outcomes, such as full recovery without fibrosis (no dead tubular epithelial cells and no increase in myofibroblasts compared with the uninjured state), fibrosis (indicated by the steady-state abundance of myofibroblasts), or organismal death (modeled as the number of dead tubular epithelial cells exceeding a preset threshold).Figure 2Theoretical Analyses Reveal the Mechanism of the Four Outcomes in Response to Renal Injury(A) Cell-cell communication model for renal homeostasis and fibrosis. The positive feedback loops are highlighted in red.(B) Simulated time series of the number of myofibroblasts under different durations of insult.(C) Repair outcomes under insult of fixed strength but increasing durations.(D) Phase diagram of repair outcomes (indicated by myofibroblast level) in the space of insult strength and duration.(E) Fraction of outcomes as a function of insult duration sampled from 1,000 independent simulations.(F) Bifurcation diagram of the myofibroblast level with respect to insult strength shows three possible survival outcomes depending on the strength of the insult.See also [Figure S2](#mmc1){ref-type="supplementary-material"} and [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}.

Under physiological conditions, the number of fibroblasts residing in the interstitial compartment is low ([@bib24]). We model these as "resident fibroblasts" ([Figure 2](#fig2){ref-type="fig"}A). In response to insult, some healthy epithelial cells ("tubular epithelium" in the model) enter the injured state ("injured tubular cells") and promote self-renewal of neighboring tubular epithelial cells. In the model, Shh promotes resident fibroblasts to transition into the state "activated fibroblast" in which they proliferate and from which they can further transition into the state "myofibroblast" ([@bib14], [@bib49]). The myofibroblasts secrete Wnt, which stimulates the proliferation of both activated fibroblasts and myofibroblasts, establishing a positive feedback loop between the myofibroblasts and Wnt production.

Wnt also affects the tubular module ([@bib25]), further promoting self-renewal and repair of injured tubular epithelial cells. Wnt also stimulates tubular epithelial cells to undergo a state transition to pEMT ("partial EMT tubular cell") ([@bib13], [@bib20], [@bib24], [@bib44], [@bib50]), which also secretes Wnt ([@bib13]). This establishes a second positive feedback loop between the partial EMT tubular cell and Wnt production.

To determine the outcomes produced by the model, we set the parameters to those for mice (see [Tables S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"} for values of parameters and initial states, see [Supplemental Information](#appsec2){ref-type="fn"}: Parameter Estimation and Justification), then monitored the distinct stable steady states produced by the model as a function of myofibroblast number by either applying a range of insult intensities ([Figure 2](#fig2){ref-type="fig"}B) or starting from a range of initial conditions ([Figure S2](#mmc1){ref-type="supplementary-material"}B). The simulated time course of the number of myofibroblasts showed that the network existed in one of three stable steady states with respect to myofibroblast abundance: return to baseline, persistent intermediate numbers of myofibroblasts, or persistent high numbers of myofibroblasts ([Figures 2](#fig2){ref-type="fig"}B and [S2](#mmc1){ref-type="supplementary-material"}B). Increasing insult duration and incorporating the number of dead tubular epithelial cells into the outcome of the model resulted in the separation of organismal death from states associated with survival and separated each of the three survival-associated steady states into those representing severe fibrosis associated with high numbers of myofibroblasts (representing MARS in the mouse experiments), low numbers of residual myofibroblasts (representing iPARS), and no fibrosis, no increase in myofibroblasts from baseline, and complete recovery of tubular epithelial cells (representing PARS) ([Figure 2](#fig2){ref-type="fig"}C). Further analysis of the cell network ([Figure S2](#mmc1){ref-type="supplementary-material"}C) suggested that the three steady states associated with survival are stable with respect to other system variables.

Consequently, we could parameterize insult by duration and strength in a 2D-phase diagram, which is divided into the four outcome domains and revealed that a short and severe insult had a similar effect as a longer but less severe one ([Figure 2](#fig2){ref-type="fig"}D). To account for the stochastic variability between mice, we simulated an ensemble of models with parameters randomly and uniformly chosen within ±20% of its default value and measured the fraction of mice exhibiting each of the four outcomes. By representing the data on a 2D-phase diagram, we showed that the fraction of mice displaying PARS decreased with increasing duration of the insult and that the fraction of mice suffering from the next higher-level severity of disease (or death) increased with increasing duration of the insult ([Figure 2](#fig2){ref-type="fig"}E). This outcome is consistent with the experimental results observed for the mice ([Figure 1](#fig1){ref-type="fig"}F).

Bifurcation Analysis Reveals Increasing Insult Severity Triggers Distinct Irreversible States {#sec2.3}
---------------------------------------------------------------------------------------------

Because the three outcomes---PARS, iPARS, and MARS---map to stable steady states of the cellular network model ([Figure 2](#fig2){ref-type="fig"}A), we performed an analysis of the irreversibility of the states using one-parameter bifurcation analysis. Under mild insult, the system ended in PARS ([Figure 2](#fig2){ref-type="fig"}F, green line) and returned to the state prior to the insult after removing the insult (with zero myofibroblasts at zero insult strength). However, increasing insult severity above a threshold ([Figure 2](#fig2){ref-type="fig"}F, SN1) resulted in the system crossing a first bifurcation point. Consequently, the system "jumped" to iPARS ([Figure 2](#fig2){ref-type="fig"}F, orange line). In this state, the system exhibited hysteresis, because reducing the insult strength to zero did not restore a completely healthy tissue composition. Instead, low levels of myofibroblasts remained. This is consistent with the preservation of kidney function that we observed in the mice ([Figures 1](#fig1){ref-type="fig"}D and 1E). With further increase of insult strength beyond a second critical point ([Figure 2](#fig2){ref-type="fig"}F, SN2), the system jumped to MARS ([Figure 2](#fig2){ref-type="fig"}F, red line), characterized by high abundance of myofibroblasts that persisted even after the insult was reduced to zero. Thus, the model predicted that both iPARS and MARS are irreversible states (for full bifurcation diagram, see [Figure S2](#mmc1){ref-type="supplementary-material"}D). That is, the system in iPARS and MARS has memory that persists even after the end of ischemia, represented as the remnants of tissue pathology or the progression to fibrosis. Parameter sensitivity analysis ([Figure S2](#mmc1){ref-type="supplementary-material"}E) revealed that all four outcomes existed within a parameter range of 15% increase or decrease of most parameters, indicating that existence of these outcomes is insensitive to heterogeneity of individual mice or our model parameter choice.

Preconditioning to iPARS Reduces Risk of Death but Increases Risk of Fibrosis {#sec2.4}
-----------------------------------------------------------------------------

Mild ischemic insults have a protective role against subsequent insults in several organ systems, such as brain, heart, liver, and kidney. Protective preconditioning is being explored as a therapeutic modality for kidney injury associated with cardiac surgery ([@bib5], [@bib17], [@bib32]). We hypothesized that mice surviving a previous AKI would be in iPARS, which would protect them against subsequent ischemic events but would increase their risk of CKD after subsequent ischemic events. We examined whether protective preconditioning is a property of our kidney cellular interaction network. We simulated a moderate renal insult (10 min) to place the system into iPARS, characterized by the absence of dead tubular cells and the presence of residual myofibroblasts ([Figure 3](#fig3){ref-type="fig"}A, solid black lines). Following a second moderate insult (15 min), the percentage of dead tubular cells reduced faster, indicating faster repair and regeneration, in the preconditioned system ([Figure 3](#fig3){ref-type="fig"}A left, red solid line) than in the control system without preconditioning ([Figure 3](#fig3){ref-type="fig"}A left, black dashed lines). Thus, our system exhibited another type of memory, i.e., a protective priming effect of preconditioning.Figure 3Double-Edged Sword Effects of Pre-fibrotic iPARS, Reducing the Risk of Death but Increasing the Risk of MARS(A) Temporal profiles of the percentage of dead tubular cells and the myofibroblast level under one 10-min insult (dashed lines) and two successive insults with one second 15-min insult occurring 30 days after the first (solid lines). The green arrow indicates the change from iPARS to MARS with pretreatment.(B) Same as (A) and (B) except with a 30-min second insult. The horizontal line indicates the threshold for death. The blue arrow indicates the change from Death to MARS with pretreatment.(C) Peak level of dead tubular cells and maximum level of the cumulative death tubular cells as a function of insult duration. The system is either preconditioned with a first moderate insult (solid red lines) or without preconditioning (black dash lines) as control.(D) (Left) Phase diagram of repair outcomes (indicated by myofibroblast level) in the space of insult strength and duration. Similar to [Figure 2](#fig2){ref-type="fig"}D, except preconditioned with a moderate insult (duration = 10 min, 30 days of recovery after first insult). Green lines indicate the threshold of MARS with (solid) and without (dashed) preconditioning. Blue lines indicate the threshold of death with (solid) and without (dashed) preconditioning. (Right) Repair outcomes under insults of fixed strength but increased durations with (red dots) and without (black boxes) preconditioning (duration = 10 min, 30 days of recovery).(E) Representative micrographs of Picro Sirius Red staining show collagen deposition in kidney cortex and juxta medulla area in both groups of pre-conditioned mice and single-IRI mice 30 days after varying degree IRI. Scale bar, 100 μm.(F--H) Dependence of the level of serum creatinine (F) (n=3), the fraction of the fibrotic area (G), and the animal death fraction (H) on the duration of IRI 30 days after IRI. Preconditioning: 10 min IRI followed by 30 days of recovery.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

However, the preconditioned system produced a high level of myofibroblasts ([Figure 3](#fig3){ref-type="fig"}A right, red solid line). Thus, the model predicted that ischemic preconditioning increases the risk of CKD. Because the preconditioned state represents iPARS, Wnt, myofibroblasts, and pEMT tubular cells are predicted to persist. This prediction is consistent with clinical observations that some patients, who survive an episode of AKI with no obvious residual impairment of renal function, have significantly increased risk of developing CKD ([@bib7], [@bib9]). Using our computational model, we also tested if repetitive mild AKI, with episodes of different duration and different spacing between episodes, increased the risk of CKD. Our model indicated that some dead tubular cells persisted after each episode and that the level of myofibroblasts increased after each episode ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B). Additionally, prolonged and more frequent exposure to mild AKI resulted in quicker development of CKD ([Figure S3](#mmc1){ref-type="supplementary-material"}C). Thus, our simulations recapitulated both the clinical and animal model observations that repetitive mild AKI also increased the risk of CKD ([@bib28], [@bib36]).

The previous simulations tested the induction of iPARS on the outcome of a mild second insult (15 min). We also tested the induction of iPARS on the outcome of a stronger second insult (30 min). An insult of this intensity is predicted to sometimes lead to death in the naive control systems ([Figures 2](#fig2){ref-type="fig"}C and 2E). Our model predicted that iPARS reduced the peak percentage and cumulative sum of dead tubular cells ([Figure 3](#fig3){ref-type="fig"}B, black dashed lines), thus preventing organism death ([Figure 3](#fig3){ref-type="fig"}B right, dotted vertical line). This reduction in dead tubular cells was predicted for a large range of durations of the second insult ([Figure 3](#fig3){ref-type="fig"}C), indicating that iPARS has a protective role in reducing the risk of death from subsequent severe renal injury.

Taken together, our model predicted that the relative benefit of ischemic preconditioning of kidneys to place them in iPARS depended on the severity of the second insult. When the second insult was severe, the benefit of ischemic preconditioning in reducing the risk of death exceeds that of the increased fibrotic risk associated with MARS, which reflects an increased risk of CKD. Ischemic preconditioning raised the threshold of death and lowered that of MARS ([Figure 3](#fig3){ref-type="fig"}D left, blue and green arrows), thus expanding the insult conditions (parameters in the model) associated with survival at the cost of increasing the risk of chronic fibrosis ([Figure 3](#fig3){ref-type="fig"}D right).

To test the mathematical predictions, we preconditioned mice by subjecting them to 10-min IRI. After 30 days of recovery, the mice survived and then were exposed to various durations of a second IRI from 10 to 30 min. We observed larger fibrotic patches in both cortex and medulla in all groups of preconditioned mice subjected to a second IRI compared with the animals only subjected to a single IRI ([Figure 3](#fig3){ref-type="fig"}E). Serum creatinine levels did not reveal an obvious change in renal function between mice subjected to preconditioning and a second IRI and those subjected to a single IRI ([Figure 3](#fig3){ref-type="fig"}F). However, quantification of the fibrotic areas revealed a significant increase of fibrosis in the preconditioned mice compared with the single IRI group ([Figure 3](#fig3){ref-type="fig"}G), consistent with the predictions of the model. Also consistent with the model predictions, we observed significant protection from death in the animals subjected to preconditioning, especially for cases of more intense insult ([Figure 3](#fig3){ref-type="fig"}H). Thus, these animal experiments recapitulated the opposing effects of preconditioning predicted by the model: Preconditioning reduced death rate at the cost of increased fibrosis.

Wnt-Mediated Positive Feedback Loops Modulate the Repair Response and Risk of Progression to CKD {#sec2.5}
------------------------------------------------------------------------------------------------

To explore the molecular origin of the four AKI outcomes, we focused on the positive feedback loop formed by the pEMT tubular cells and Wnt ([Figure 2](#fig2){ref-type="fig"}A). We selected this feedback loop because it represents a critical aspect of tissue repair (pEMT tubular cells) and a major contributing factor to fibrosis (Wnt secretion that stimulates myofibroblast expansion). With the model, we tested the effect of altering Wnt signaling on the outcome of injury ([Figure 4](#fig4){ref-type="fig"}). From a clinical standpoint, Wnt signaling represents a potentially pharmacologically manipulatable aspect of the injury response; thus, we focus on the results of those simulations.Figure 4The pEMT-Wnt Axis Modulates Repair Response and Progression Risk to CKD(A) Bifurcation diagram with overexpressed Wnt (increased secretion rate, red lines) or downregulated Wnt (reduced secretion rate, blue lines) in contrast to the control (Ctrl, black lines).(B) Repair outcomes under insults of fixed strength but increasing durations with (blue dots) and without (black boxes, control) constant Wnt downregulation.(C) Phase diagram of repair outcomes (indicated by myofibroblast level) in the space of insult strength and duration with constant downregulated Wnt. Dashed lines indicate boundaries in the control system (without Wnt downregulation).(D) Repair outcomes under insults of fixed strength but increasing durations of IRI with (red dots) and without (black boxes, control) Wnt constant overexpression.(E) Same as panel C except with constant Wnt overexpression. Dash lines represent the boundaries in the control system (without Wnt overexpression).(F) Effect of Wnt agonist treatment before AKI on repair outcome under various insult duration.

We simulated the outcomes in the cellular network model by perturbing the activity of Wnt. When we reduced Wnt in the network model, the system tolerated higher insult intensities before jumping to either iPARS or MARS ([Figure 4](#fig4){ref-type="fig"}A, blue lines compared with black lines). When we increased Wnt, the system jumped to iPARS and MARS at lower insult intensities ([Figure 4](#fig4){ref-type="fig"}A, compare red lines with black lines). These results indicated that reducing Wnt in the presence of a continuous low-intensity insult was protective, increasing the threshold of MARS and making the maladaptive response less likely, whereas increasing Wnt had the opposite effect under these conditions.

We also simulated the outcomes in response to a single transient insult of varying duration representing AKI, while increasing or decreasing Wnt ([Figures 4](#fig4){ref-type="fig"}B--4E). When Wnt was reduced, there were only three states: PARS, iPARS, and death. The insult durations that resulted in death or iPARS increased, expanding those states and eliminating MARS ([Figures 4](#fig4){ref-type="fig"}B and 4C). Conversely, when Wnt was increased, the insult durations that resulted in MARS increased and fewer resulted in death or iPARS ([Figures 4](#fig4){ref-type="fig"}D and 4E), thus raising the threshold for death and lowering that for MARS.

We simulated the effect of Wnt agonists added prior to a single transient insult of varying duration. The model predicted that pretreatment with Wnt agonists raised the threshold of death and expanded the insults that resulted in MARS ([Figure 4](#fig4){ref-type="fig"}F). The predicted reduction in death is consistent with a report that treatment with Wnt reduced the kidney damage and improved renal function in an IRI rat model ([@bib19]). Inspection of the transition between iPARS and MARS ([Figure 4](#fig4){ref-type="fig"}F) suggested that the effect of Wnt pathway activity was biphasic: The threshold of MARS first increased (reflecting a safer effect of Wnt treatment) and then decreased as Wnt agonists increased. These results predicted that the therapeutic window for Wnt activation that minimizes both the risk of death from acute injury and the development of chronic fibrosis is narrow.

Consistently, increasing the Wnt secretion rate in the model increased the death threshold and decreased the MARS threshold ([Figure 4](#fig4){ref-type="fig"}F). That is, the renal system faces a fundamental trade-off between CKD (represented as MARS) and death, so reducing the risk of death increases the risk of CKD and vice versa. Thus, the model predicted that the consequences of manipulating Wnt consistently throughout the injury response are complicated and depend on the condition (low intensity and continuous injuries, like CKD, or transient injury, like AKI). In CKD, reducing Wnt is predicted to be protective. However, in AKI, reducing Wnt is predicted to increase the risk of death. Furthermore, adding Wnt agonists as a pretreatment strategy is predicted to have a narrow optimal activity window.

Achieving Optimal Treatment of AKI by Dual Targeting of Repair and Resolution Dynamics {#sec2.6}
--------------------------------------------------------------------------------------

In view of the trade-off between repair and fibrosis and the narrow therapeutic window of Wnt activity predicted by our cellular interaction model, we hypothesized that an optimal strategy targeting Wnt would combine activation and inhibition in a temporally controlled manner, thereby promoting both the repair and resolution phases of the injury response. Thus, we formulated it as a computational multi-objective optimization problem and used a Metropolis search to evaluate Wnt-targeted regimens by varying the schedules, durations, and dosages of both Wnt antagonists and agonists ([Figure 5](#fig5){ref-type="fig"}A, see [Methods](#sec4){ref-type="sec"}). The ideal strategy minimizes both the risks of death and fibrosis and achieves the fastest recovery using the lowest doses of drugs with the shortest treatment time. Practically the optimization process is to minimize a score function that includes all these factors with the highest weight given to reducing the risk of death, followed by the weight for reducing the risk of fibrosis. As expected, the optimal strategy required treatment with a Wnt agonist at the beginning followed by treatment with a Wnt antagonist ([Figures 5](#fig5){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}A). Simulation of 1,000 mice, each with parameters drawn from a distribution to account for individual heterogeneity confirmed the robustness of the treatment scheme with the most mice under a combined treatment of Wnt agonist and antagonist reaching PARS and a small fraction reaching iPARS ([Figure 5](#fig5){ref-type="fig"}C). Our model also predicted that the optimal treatment design depends on insult duration ([Figures S4](#mmc1){ref-type="supplementary-material"}B and S4C).Figure 5Temporal Regulation of Wnt Represents the Optimal Dynamic Treatment Design for AKI through Temporal Regulation of Wnt(A)Schematic of treatment design combining Wnt and its inhibitor, with parameters to be optimized including the doses, timings, and durations of Wnt and inhibitor.(B) Representative searching trajectory of the therapy score function and treatment design over Monte Carlo steps. The weights of different factors \[λ1, λ2, λ3, λ4, λ5\] in the score function are set as \[500, 10, 1, 1, 1\].(C) Fraction of various repair outcomes under different treatment designs---Wnt agonist only (Wnt Ag), Wnt antagonist (Wnt Antag), or combination of Wnt agonist and antagonist---and the control system without treatment, each sampled from 1,000 simulations.(D) Fractions of repair outcomes as a function of insult duration with the optimal design for the 30-min insult. Dashed lines are corresponding region boundaries without treatment (yellow, PARS/iPARS; red, iPARS/MARS; black, MARS/Death). Each result was sampled from 1,000 independent simulations.(E--I) Representative micrographs of Picro Sirius Red staining (E), the fraction of fibrotic area (F), quantitative real-time RT-PCR (qRT-PCR) for collagen type III and TNC (G and H) on day 30 and the fraction of animal death (I) (within 30 days) after 30-min IRI with pre-administration of Wnt treatment or with Wnt inhibitor ICG-001 administration from day 4 to day 30 or combination of Wnt pre-administration and ICG-001 administration from day 4 to day 30 or without any treatment. Scale bar, 100 μm. ∗∗p \< 0.01 versus labeled groups using one-way ANOVA, followed by the Student-Newman-Keuls test (n = 4--6). For (I), the total number of mice is 9--16 for each group. For (F)--(H), data are represented as mean ± SEM.See also [Figures S4--S6](#mmc1){ref-type="supplementary-material"} and [Table S3](#mmc1){ref-type="supplementary-material"}.

To validate our therapeutic strategy, we used a 30-min IRI and tested four different treatment designs in mice: IRI only, a single Wnt1 pretreatment prior to IRI, Wnt signal inhibitor ICG-001 treatment administered every day from day 4 to day 13 after IRI, and combined treatment with Wnt1 before IRI and ICG-001 after IRI. Of note, the Wnt1 pretreatment was based on the hydro-dynamic gene delivery technique. [Figure S5](#mmc1){ref-type="supplementary-material"} illustrated that HA-tagged Wnt1 gene was effectively delivered to the kidneys. Histochemical analysis showed that fibrosis was markedly reduced in the groups receiving ICG-001 alone or in combination with Wnt1 pretreatment; pretreatment with Wnt1 alone increased the severity of fibrosis ([Figures 5](#fig5){ref-type="fig"}E and 5F). Compared with the IRI-only group, we observed a reduction of components of the extracellular matrix, indicating reduced extracellular matrix deposition, in the groups with combined treatment or ICG-001-only treatment, whereas Wnt1 pretreatment alone increased extracellular matrix deposition ([Figures 5](#fig5){ref-type="fig"}G and 5H). Either Wnt1 pretreatment alone or the combination treatment enhanced survival to this severe insult ([Figure 5](#fig5){ref-type="fig"}I). In the absence of ischemic insults, administration of either Wnt1 or ICG-001 alone had little effect ([Figure S6](#mmc1){ref-type="supplementary-material"}), recapitulating our previous findings ([@bib42], [@bib51]).

Taken together, the prediction from theoretical analysis and preclinical studies in a mouse model for AKI and CKD suggested that combined sequential treatment with Wnt agonists and antagonists can overcome the dilemma of the double-edged-sword effect of Wnt pathway activity and minimize both animal death and kidney fibrosis.

Discussion {#sec3}
==========

Tissue injury and its repair pose a conundrum that lies at the intersection between recovery from acute disease and the development of chronic disease. The unleashing of a well-orchestrated and rapid response that fixes the parenchymal tissue defect through a transient mesenchymal proliferative response must be tightly controlled to prevent chronic fibrosis caused by the response itself. Thus, tissue repair that ensures survival ranges from full reconstitution to chronic disease. The latter represents an evolutionary trade-off that prioritizes survival over avoidance of proliferative fibrotic disease.

We used an established animal model for acute ischemic kidney injury in the mouse to study the trade-off using both experimental and mathematical analyses. By multi-variable molecular, morphological, and functional assessment, we identified three distinct response types of kidney tissue with respect to its adaptation to the insult: full recovery of the healthy tissue (PARS), functional recovery with residual tissue alterations (iPARS), and progressive chronic disease with fibrosis (MARS).

It is increasingly believed that the acute and chronic forms of kidney disease do not reflect distinct types of diseases with different etiologies. Instead, both forms are distinct responses to the same type of insult, such as ischemia, occurring at varying intensity. Thus, the system is a dynamical one producing qualitatively distinct behaviors in response to a quantitative continuum of perturbation. The emergence of multiple qualitatively distinct behaviors is a central characteristic of non-linear dynamical systems. Therefore, dynamical systems theory is an appropriate method for analyzing the system representing the kidney injury response.

In constructing a mathematically tractable model, we focused on the repair of the cellular damage mediated by well-characterized cell-to-cell interactions. The dynamics of the cell interaction network ([Figure 2](#fig2){ref-type="fig"}A) exhibited multistable dynamics that mapped to the four observed disease fates: PARS, iPARS, MARS, and death. Theoretical analysis of the model made a number of predictions that were experimentally confirmed and explained long-observed phenomena ([Figure 6](#fig6){ref-type="fig"} and [Table S3](#mmc1){ref-type="supplementary-material"}). Multistability and memory are the most elementary manifestations of non-linear dynamics and require positive feedback loops in the system architecture ([@bib3]). Memory is a manifest of irreversibility, which emerges owing to hysteresis in the dynamics. Physiologically, memory is represented in iPARS as the remnants of tissue pathology that persist long after the end of ischemia and in MARS as the progression to fibrosis. Memory is also represented by the protective priming effect of pre-conditioning, a phenomenon seen in several ischemic organ diseases. Thus, the kidney repair program keeps a "memory" of previous injury and is primed for a more rapid response to subsequent injury but at the expense of increased risk of fibrosis. Future studies may further reveal the molecular mechanisms of the memory, including possible roles of epigenetic modifications.Figure 6Summary of the Renal Repair ProcessIn response to injury, the renal repair system is initialized to reduce the damage through cell regeneration. If too many tubular cells are dead without timely replenishment, immediate death may happen. Otherwise, the repair process continues and generates myofibroblast that produces extracellular matrix (ECM). If too much ECM accumulates, the system goes into MARS and develops renal fibrosis. If the ECM level is low and the level of myofibroblasts does not reset to the pre-injury level, the system goes into iPARS. If all the components are completely reset to their normal states, the system goes into PARS. See also [Table S4](#mmc1){ref-type="supplementary-material"}.

The double-edged nature of molecular players that could serve as therapeutic targets poses a dilemma for treatment. Specifically, Wnt represents an important lever point for pharmacological intervention. However, Wnt plays opposing roles, which are captured in our model: in the acute phase, it is a positive regulator of regeneration by promoting stem-like states and stimulating myofibroblast expansion. However, the latter role of Wnt signaling drives fibrosis in the chronic phase. Some studies indicate renal tubular cells undergoing pEMT are a potential target for intervention as tubular cells in pEMT state secrete various cytokines to promote the fibrosis ([@bib13], [@bib24]), and others focus on the activation of resident fibroblasts as a site for intervention because these cells are a source of the fibrogenic myofibroblasts ([@bib13], [@bib21], [@bib24], [@bib29], [@bib31]). Both mathematical modeling and experimental studies have identified key pEMT regulators, such as Snail1, HIPK2, NF-κB, and Twist1 ([@bib13], [@bib16], [@bib24], [@bib37], [@bib43], [@bib47]), which may be combined with other targets, such as Wnt and Shh, for designing optimal treatment against both AKI and CKD ([@bib26], [@bib48]). However, these approaches commonly rest on the conventional paradigm of linear causation embodied by molecular pathways that only need to be manipulated in one direction (enhanced or inhibited), ideally at multiple points in the network by combination therapy.

However, such unidirectional up- or downregulation of pathways cannot address the complexity of a trade-off response. Because of the double-edged effect, a unidirectional (unimodal) intervention in the repair program is unlikely to achieve speedy repair and complete resolution, free of unintended consequences. Thus, we focused on the double-edged sword effect of Wnt as a potential target, for which both agonists and antagonists exist. We formulated a treatment design as an optimization problem. Our computational optimization procedure proposed a regimen that we implemented in the animal AKI model, demonstrating that a temporal combination of applying a Wnt agonist and a Wnt antagonist thereafter can both prevent death by promoting rapid repair as well as reduce the development of fibrosis. That is, Wnt antagonists could prevent fibrosis. However, Wnt signaling is necessary to activate regenerative programs. Indeed, in studies with mice, Wnt agonists administered prior to an ischemic episode reduce kidney damage and improve renal function ([@bib19]). The key to using Wnt pathway-targeted therapies is timing the application of the agonists and antagonists. Agonists need to be administered early after the injury to promote repair, whereas antagonists need to be administered later to enable resolution and limit fibrosis. Future studies with time-controlled, cell-type-specific genetic models are warranted to further address this issue.

While the broader applicability of our procedure of optimizing the dual use of antagonist and agonist to control the non-linear dynamics of the repair process remains to be further evaluated in human and other disease models, our results suggest that, to confront a pathogenetic mechanism that involves a target that is a double-edged sword, we need to think beyond the standard unidirectional inhibition (or activation) of a single target or pathway. As a first step, our work establishes the rationale for a new modality of non-monotonical pharmacological intervention to control non-linear disease dynamics by biphasic application of both agonists and antagonists of the same target. The insights provided by the current work may guide potential therapeutic strategies, which would need rigorous investigation before any practical clinical intervention.

Limitations of the Study {#sec3.1}
------------------------

In this work, we presented a proof-of-concept study focusing on Wnt signaling in the context of fibrosis. Our model robustly predicts key dynamic features of the repair response that underlies the pathogenesis. As with any model, some simplification is necessary to enable computational study. Two cell types (tubular epithelial cells and fibroblast cells) and two pathways (Shh and Wnt) are considered in the model, which works despite the simplicity. Thus, our model implicitly but not explicitly takes into account a number of molecular mechanisms known to take part in the response, such as several inflammatory cytokines, growth factors, autacoids, and ECM ([@bib6]). By focusing on regeneration that repairs the cellular deficit caused by ischemic destruction, we omit inflammatory infiltrates and ensuing angiogenesis. Through implementing these processes and their actively controlled termination, future studies may fine-tune the model description of disease course with genetic mouse models. In addition, our cell-cell interaction model describes tissue-level changes (as defined by cell and matrix composition) and does not consider the granularity to describe gene expression changes and associated epigenetic alterations that govern the cell state dynamics and have been implicated in the memory of AKI ([@bib27], [@bib33], [@bib45]). The spatial aspects were not considered in the model. Considering spatial aspects in the mathematic model and targeting the EMT plasticity will further optimize the treatment design ([@bib12]).

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Code Availability {#appsec1}
==========================

All data produced or analyzed for this study are included in the published article and its supplementary information files or are available from the corresponding author upon reasonable request. All the equations and parameters of the mathematical models can be found in [Transparent Methods](#mmc1){ref-type="supplementary-material"}.
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